Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Understand how zero based budgeting stacks up against traditional monthly methods and which approach best suits your financial goals.
18,282 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Aurora Mobile's Q1 2026 earnings reveal a mix of solid growth and evolving margins. This piece breaks down what the t...
Space is shifting from science fiction to a real investment theme. This guide breaks down how the final frontier beco...
As mortgage costs stay elevated, Opendoor racked up another quarterly loss. Forget opendoor technologies: this turns ...
OpenAI signals pricing tilt as competition heats up. New usage data shows AI demand cooling, pushing executives to co...
On June 11, 2026, Suze Orman advised a caller with $600,000 to manage the portfolio themselves rather than pay a 1.5%...
A single AI infrastructure stock delivered an eye-popping 4,800% gain in 12 months. Here’s what drove that rally, wha...
Celebrity fashion moments can become financial talking points. This guide explains how to evaluate, insure, and sell ...
Take-Two CEO Strauss Zelnick is directing a record-setting $1.5 billion launch budget for GTA VI, a move investors wi...
A 64-year-old with $1.5 million in retirement assets faces a costly year before Medicare, as ACA premiums and uncover...
SpaceX held firm through a choppy month, outperforming peers in the space stock group. The market’s rotation favored ...
Intel stock looks beaten in the near term, but long-term possibilities remain. This guide breaks down the factors tha...